Ticker Details
Eton Pharmaceuticals, Inc. Common Stock
IPO Date:	November 13, 2018
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$739.41M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.20 | 2.67%
Avg Daily Range (30 D):	$0.57 | 2.73%
Avg Daily Range (90 D):	$0.38 | 2.08%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	.35M
Avg Daily Volume (90 D):	.25M

Trade Size
Avg Trade Size (Sh.):	107
Avg Trade Size (Sh.) (30 D):	60
Avg Trade Size (Sh.) (90 D):	59

Institutional Trades
Total Institutional Trades:	107
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$1.03M
Avg Institutional Trade (90 D):	$1.07M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.73M
Avg Closing Trade (30 D):	$1.14M
Avg Closing Trade (90 D):	$1.15M
Avg Closing Volume:	134K

News

Mar 2, 2026 @ 12:27 PM Eton Pharmaceuticals Expands Rare Disease Portfoli... Source: Globe Newswire

Feb 25, 2026 @ 6:47 PM Eton Pharmaceuticals Announces U.S. FDA Approval f... Source: Na

May 9, 2024 @ 8:01 PM Eton Pharmaceuticals Reports First Quarter 2024 Fi... Source: Eton Pharmaceuticals

May 1, 2024 @ 8:05 PM Eton Pharmaceuticals to Present at the Citizens JM... Source: Eton Pharmaceuticals

Apr 30, 2024 @ 11:00 AM Eton Pharmaceuticals Announces Submission to FDA o... Source: Eton Pharmaceuticals

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.17	$.06	$-.17
Diluted EPS
Revenue	$79.95M	$21.28M	$79.95M
Gross Profit	$42.74M	$13.1M	$42.74M
Net Income / Loss	$-4.6M	$1.48M	$-4.6M
Operating Income / Loss	$-.84M	$2.46M	$-.84M
Cost of Revenue	$37.21M	$8.18M	$37.21M
Net Cash Flow	$11.01M	$-11.18M	$11.01M
PE Ratio